CNS Pharmaceuticals, Inc. (CNSP)
4.97
+0.22
(+4.63%)
USD |
NASDAQ |
Oct 23, 16:00
4.97
0.00 (0.00%)
After-Hours: 20:00
CNS Pharmaceuticals Net Income (Quarterly) : -2.588M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.588M |
| March 31, 2026 | -4.937M |
| December 31, 2025 | -5.956M |
| September 30, 2025 | -3.218M |
| June 30, 2025 | -2.375M |
| March 31, 2025 | -4.301M |
| December 31, 2024 | -3.176M |
| September 30, 2024 | -5.606M |
| June 30, 2024 | -2.531M |
| March 31, 2024 | -3.545M |
| December 31, 2023 | -5.375M |
| September 30, 2023 | -4.523M |
| June 30, 2023 | -4.021M |
| March 31, 2023 | -4.932M |
| December 31, 2022 | -5.504M |
| September 30, 2022 | -3.420M |
| June 30, 2022 | -3.566M |
| Date | Value |
|---|---|
| March 31, 2022 | -3.152M |
| December 31, 2021 | -2.795M |
| September 30, 2021 | -3.814M |
| June 30, 2021 | -3.814M |
| March 31, 2021 | -3.613M |
| December 31, 2020 | -3.005M |
| September 30, 2020 | -2.011M |
| June 30, 2020 | -2.474M |
| March 31, 2020 | -1.968M |
| December 31, 2019 | -2.527M |
| September 30, 2019 | -0.7067M |
| June 30, 2019 | -0.4317M |
| March 31, 2019 | -0.2115M |
| December 31, 2018 | -6.632M |
| September 30, 2018 | -0.1932M |
| June 30, 2018 | -0.2575M |
| March 31, 2018 | -0.3097M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 210.00M |
| Eli Lilly & Co. | 7.095B |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 2.588M |
| EPS Diluted (Quarterly) | -0.3785 |
| Enterprise Value | -12.72M |
| Earnings Yield | -474.7% |
| Normalized Earnings Yield | -474.68 |